GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Oruka Therapeutics Inc
Oruka Therapeutics, a biotech company developing treatments for skin diseases, is valued in the private market based on the progress of its research programs. The potential post-IPO share price will depend on the results of clinical trials.
Share prices of companies in the market segment - Pharma skin
Oruka Therapeutics is a clinical-stage biotech company developing drugs for chronic skin diseases such as psoriasis. We've classified it in the "Pharmaceuticals (Skin Diseases)" segment, which is actively pursuing new solutions. The chart below shows the overall investor sentiment in this highly specialized field.
Broad Market Index - GURU.Markets
Oruka Therapeutics is a biopharmaceutical company focused on developing treatments for chronic skin diseases. Its innovative approach makes it a component of the GURU.Markets index. The chart below compares its performance with the overall market.
Change in the price of a company, segment, and market as a whole per day
ORKA - Daily change in the company's share price Oruka Therapeutics Inc
Shares of Oruka Therapeutics, a dermatology company, exhibit the extreme volatility typical of biotech. change_co tracks investor reactions to the publication of research data. This parameter is key for building high-risk asset valuation models on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma skin
Oruka Therapeutics Inc is a biotech company. This chart highlights the extreme volatility of the sector. Comparing ORKA's performance, which is dependent on clinical trial results, helps assess it as a high-risk asset compared to more diversified companies.
Daily change in the price of a broad market stock, index - GURU.Markets
Oruka is a biopharmaceutical company developing drugs to treat skin diseases. Dermatology is a competitive segment of the pharmaceutical industry. The chart below shows the average volatility in this niche, allowing investors to compare Oruka's stock performance with other companies in the sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Oruka Therapeutics Inc
Oruka is a biopharmaceutical company focused on dermatology. Its shares are driven by successful drug commercialization and clinical trial results. The dynamics of this niche healthcare segment are part of a larger and more diverse picture of the overall stock market.
Annual dynamics of market capitalization of the market segment - Pharma skin
Oruka Therapeutics, a private biotech company, develops drugs to treat inflammatory diseases. Its growth depends on success in clinical trials. Its valuation reflects investor confidence in its scientific platform, potentially outperforming the overall pharmaceutical sector, but with higher risks.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Oruka Therapeutics is a clinical-stage biotech whose fate since its IPO has depended on scientific breakthroughs, not the state of the economy. Its stock price reflects investor hopes for the success of new drug trials. The company's chart exists in a world of its own, where the main events are data releases.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Oruka Therapeutics Inc
Gold Royalty is a company that owns the rights to royalties from gold mining. Its monthly fluctuations reflect gold prices and news from the mines from which it generates revenue. This makes it less risky than traditional miners.
Monthly dynamics of market capitalization of the market segment - Pharma skin
Oruka Therapeutics is a young biotech company focused on developing treatments for chronic skin diseases. This pharmaceutical sector is attracting significant attention due to the large number of patients affected. The industry's dynamics reflect a general expectation for new, more effective treatments, and Oruka is seeking to carve out its niche with an innovative approach.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Oruka Therapeutics Inc. is a biopharmaceutical company focused on developing new treatments for chronic skin diseases and inflammation. The company's future depends solely on the success of its clinical trials. The broader market chart serves as a contrasting backdrop to illustrate how scientific news and the potential of its platform have impacted its valuation in the biotech world.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Oruka Therapeutics Inc
Oruka Therapeutics (recent IPO) is a biotech company. Early weekly performance will reflect overall sentiment in the sector and any news about the progress of its scientific platform.
Weekly dynamics of market capitalization of the market segment - Pharma skin
Oruka Therapeutics is a biotech company. Comparing its weekly performance to the broader biotech sector would only highlight its uniqueness. The chart would show how news about its scientific platform would drive its stock price movement independently of overall trends.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Shares of Oruka, a biotech company, would exist in a world of their own. Their performance would be determined by news of scientific breakthroughs. A chart comparing them to the S&P 500 would clearly demonstrate how the stock could move regardless of the broader market.
Market capitalization of the company, segment and market as a whole
ORKA - Market capitalization of the company Oruka Therapeutics Inc
Oruka Therapeutics' market cap, had it gone public, would have been a story about the development of a new generation of biologic drugs for chronic skin diseases like psoriasis. Its price chart would reflect investors' faith in its scientific approach and potential to compete in the vast dermatology market.
ORKA - Share of the company's market capitalization Oruka Therapeutics Inc within the market segment - Pharma skin
Oruka Therapeutics is a biotech company specializing in developing new treatments for chronic skin diseases such as psoriasis. Its market share reflects the potential of its scientific platform to create more effective and safer drugs. The chart below shows the market's confidence in its future drugs.
Market capitalization of the market segment - Pharma skin
Oruka Therapeutics is a biopharmaceutical company developing new treatments for chronic skin diseases such as psoriasis. The chart below shows the overall market capitalization of the skin pharmaceuticals sector. It reflects a large and competitive market in which Oruka is attempting to carve out a niche through innovative approaches.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart shows a biotech company targeting skin diseases. Oruka Therapeutics is developing drugs to treat psoriasis and other dermatological conditions. Its market cap (post-IPO) will reflect its progress in clinical trials and its potential in the vast skincare market.
Book value capitalization of the company, segment and market as a whole
ORKA - Book value capitalization of the company Oruka Therapeutics Inc
Oruka Therapeutics' foundation is its scientific platform for developing new biologics for the treatment of chronic skin diseases such as psoriasis. This represents cutting-edge scientific capital. The chart shows how the biotech company, spun out from another firm, is accumulating resources to fund its ambitious research in dermatology.
ORKA - Share of the company's book capitalization Oruka Therapeutics Inc within the market segment - Pharma skin
Oruka Therapeutics is a biotech company focused on treating chronic skin diseases. Its assets are based on scientific research. The chart shows a minimal share of physical assets, typical for an early-stage company whose value lies in the potential of its research.
Market segment balance sheet capitalization - Pharma skin
Developing skin treatments, like Oruka Therapeutics', is a knowledge-intensive but relatively "easy" business at the R&D stage. Its value lies in its patents. Compared to the capital-intensive pharmaceutical sector, the company's model doesn't require the ownership of large manufacturing plants.
Book value of all companies included in the broad market index - GURU.Markets
Oruka Therapeutics' assets are not factories, but capital and intellectual property, focused on developing new treatments for chronic skin diseases such as psoriasis. The book value reflects the financial resources available for clinical trials. The chart illustrates the scale of this dermatology biotech company.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Oruka Therapeutics Inc
For Oruka, a biotech company focused on dermatology, market capitalization reflects its belief in its scientific approach. Its ratio to book value (its equity) reflects the premium the market is willing to pay for the potential to develop new drugs for skin diseases.
Market to book capitalization ratio in a market segment - Pharma skin
Oruka Therapeutics is a biotech company specializing in the treatment of chronic skin diseases. Its market capitalization is based on the expected future success of its scientific platform. The chart demonstrates investor confidence in the potential of its developments.
Market to book capitalization ratio for the market as a whole
Oruka Therapeutics is a preclinical biotech company developing new treatments for chronic skin diseases such as psoriasis. Its valuation is based entirely on its belief in its scientific approach. This metric demonstrates how the market values companies in the earliest stages, long before any clinical data is available.
Debts of the company, segment and market as a whole
ORKA - Company debts Oruka Therapeutics Inc
Oruka Therapeutics, an early-stage biotech developing new treatments for skin diseases, is entirely venture-funded. Debt is not a typical financing instrument at this stage. This chart reflects the initial phase of its development, when all resources are focused on preclinical research.
Market segment debts - Pharma skin
Oruka Therapeutics is a preclinical biotech company focused on developing new treatments for chronic skin diseases such as psoriasis. This chart depicts the startup's financial model, which is raising venture capital to fund its early, yet potentially breakthrough, research in immunology.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Oruka Therapeutics Inc
Oruka Therapeutics is a biotech company developing new treatments for chronic skin diseases such as psoriasis. Clinical trials in dermatology require significant investment and time. This chart shows how the company uses debt to fund its research and development, reflecting the financial risks involved in developing a new drug.
Market segment debt to market segment book capitalization - Pharma skin
Oruka Therapeutics is a biopharmaceutical company focused on treating chronic skin diseases such as psoriasis. This market is large and competitive. This chart shows how the company finances its clinical trials. It compares its debt structure to the overall financial picture in the capital-intensive biotech sector.
Debt to book value of all companies in the market
Oruka Therapeutics is an early-stage biotech company focused on treating chronic skin diseases. Developing drugs from scratch requires massive investment. How heavily will the company rely on debt? This graph of total debt in the economy provides context for assessing the future risks of its financial model in a highly competitive industry.
P/E of the company, segment and market as a whole
P/E - Oruka Therapeutics Inc
Oruka Therapeutics is a biotech company specializing in developing treatments for chronic skin diseases such as psoriasis. This chart, which appeared after the IPO, reflects investor interest in new approaches in dermatology. The valuation is based on the scientific potential of its platform and early research data.
P/E of the market segment - Pharma skin
Oruka Therapeutics is a biotech company specializing in developing new treatments for chronic skin diseases such as psoriasis and atopic dermatitis. This chart shows the average market value for the sector, helping to understand how the market views Oruka's scientific approach to immunology.
P/E of the market as a whole
Oruka Therapeutics is a biotech company developing drugs to treat chronic skin diseases such as psoriasis. This is a huge market. Does the company's valuation reflect the general investor interest in immunology, or is it a unique bet on its scientific approach and ability to create best-in-class drugs?
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Oruka Therapeutics Inc
Oruka Therapeutics is a biotechnology company specializing in the development of new treatments for chronic skin diseases such as psoriasis. This chart reflects analyst expectations regarding the potential of its research and development pipeline. Future profits depend on the success of clinical trials and entry into a competitive market.
%20P%2FE%20Oruka%20Therapeutics%20Inc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Oruka-Therapeutics-Inc&v=1772676194562 "Chart of the company's future (projected) P/E Oruka Therapeutics Inc")
Future (projected) P/E of the market segment - Pharma skin
Oruka Therapeutics is a biopharmaceutical company using a structure-based approach to develop potentially best-in-class biologics for the treatment of chronic skin diseases and other inflammatory conditions. The chart shows industry forecasts, allowing us to compare market confidence in Oruka's scientific platform with expectations from other companies.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-skin&v=1772676194579 "Future (projected) P/E graph of the market segment - Pharma skin")
Future (projected) P/E of the market as a whole
Oruka Therapeutics Inc. is a biotech company specializing in the treatment of chronic skin diseases such as psoriasis. Its valuation depends on the success of clinical trials. This graph of overall risk appetite shows how willing investors are to invest in long-term, risky biotech projects with a large potential market.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772676194619 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Oruka Therapeutics Inc
Oruka Therapeutics (newly established) focuses on developing new treatments for chronic skin diseases such as psoriasis. Being in the very early stages, its financial results will reflect research costs only. A future schedule will show the cost of developing innovative dermatological drugs.
Profit of companies in the market segment - Pharma skin
Oruka Therapeutics is a biotech company specializing in developing new treatments for chronic skin diseases such as psoriasis. This chart, showing the pharmaceutical sector's profitability, is an indicator of investment appetite. Their goal is to create more effective and safer drugs, and their success depends on the results of clinical trials and the competitive environment.
Overall market profit
Oruka Therapeutics is a biotechnology company developing new treatments for chronic skin diseases such as psoriasis. Its success depends on clinical trial results and the competitive environment. Overall economic stability, reflected in this chart, is important for attracting the investment needed to bring innovative dermatological drugs to market.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Oruka Therapeutics Inc
Oruka Therapeutics is a biotech company developing new biologic drugs for the treatment of chronic skin diseases such as psoriasis. Its goal is to create safer and more effective medications. This chart summarizes analyst opinions on the potential of their developments and the likelihood of success in clinical trials in a highly competitive market.
%20profit%20of%20the%20company%20Oruka%20Therapeutics%20Inc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Oruka-Therapeutics-Inc&v=1772676194713 "Graph of future (projected) profit of the company Oruka Therapeutics Inc")
Future (predicted) profit of companies in the market segment - Pharma skin
Oruka Therapeutics is a biotech company developing new treatments for chronic skin diseases such as psoriasis. Its value lies in the potential of its scientific developments. This chart for the pharmaceutical sector shows the overall market expectation for innovative therapies in major areas such as dermatology and the belief in the emergence of new effective drugs.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-skin&v=1772676194791 "Graph of future (predicted) profits of companies in a market segment - Pharma skin")
Future (predicted) profit of the market as a whole
Oruka Therapeutics is a development-stage biotech focused on treating chronic skin diseases. Its value is derived from the potential of its scientific discoveries. This graph, reflecting overall profit expectations, influences investors' risk appetite, which is critical for funding its R&D.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772676194895 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Oruka Therapeutics Inc
Oruka Therapeutics is a biotech company developing new treatments for chronic skin diseases. For an early-stage company, this chart is key. It shows how investors view its scientific approach and the enormous potential for future revenue if its drugs are successful in treating common conditions like psoriasis.
P/S market segment - Pharma skin
Oruka Therapeutics is a biotech company specializing in developing new treatments for chronic skin diseases such as psoriasis. Its valuation is based on the future potential of its drugs. This chart reflects the average valuation in the sector, allowing investors to understand the high expectations for Oruka's scientific approach and developments.
P/S of the market as a whole
Oruka Therapeutics is a biopharmaceutical company developing new treatments for chronic skin diseases such as psoriasis. This chart, which reflects revenue estimates for traditional companies, highlights that Oruka's value stems from investors' faith in its ability to create more effective and safer treatments for the millions of people suffering from inflammatory skin conditions.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Oruka Therapeutics Inc
Oruka Therapeutics is a preclinical biotech company focused on developing drugs for the treatment of chronic skin diseases such as psoriasis. This chart reflects investors' confidence in the potential of its scientific approaches to create new, more effective, and safer medications for a wide range of patients.
%20P%2FS%20Oruka%20Therapeutics%20Inc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Oruka-Therapeutics-Inc&v=1772676195120 "The graph of the company's future (projected) P/S Oruka Therapeutics Inc")
Future (projected) P/S of the market segment - Pharma skin
Oruka Therapeutics Inc. is a preclinical-stage biopharmaceutical company focused on developing novel biologic therapies for the treatment of chronic skin diseases such as psoriasis. This chart shows the average estimated future sales in the biotech sector. It helps understand how highly the market values Oruka's potential in dermatology.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20skin&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-skin&v=1772676195206 "Future (projected) P/S market segment graph - Pharma skin")
Future (projected) P/S of the market as a whole
Oruka Therapeutics is a clinical-stage biotech company developing new treatments for chronic skin diseases such as psoriasis. This chart shows investor revenue growth expectations. Oruka's success could bring more effective and safer drugs to market, opening a multi-billion-dollar market and improving the lives of millions of people.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772676195224 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Oruka Therapeutics Inc
This chart illustrates the revenue of Oruka Therapeutics, an early-stage biopharmaceutical company developing new treatments for chronic skin diseases such as psoriasis. At this stage, its revenue likely consists of partnership fees, reflecting scientific progress, rather than ongoing commercial sales.
Sales of companies in the market segment - Pharma skin
Oruka Therapeutics Inc. is a biotechnology company developing new treatments for chronic skin diseases such as psoriasis. This graph illustrates the growth of the dermatology market. Oruka's innovative approaches to creating more effective and safe drugs can offer patients better treatment options and capture a significant share of this large and competitive segment.
Overall market sales
Oruka Therapeutics is a biotech company developing treatments for chronic skin diseases. Its prospects depend on research and partnerships. The overall economic climate, reflected in this chart, influences the investment climate in the biotech sector, which influences the company's funding.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Oruka Therapeutics Inc
Oruka Therapeutics is a biotechnology company specializing in the development of drugs for the treatment of chronic skin diseases such as psoriasis. Its revenue projections are based on the expected success of its clinical programs and its potential in the large dermatology market.
%20sales%20of%20the%20company%20Oruka%20Therapeutics%20Inc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Oruka-Therapeutics-Inc&v=1772676195423 "Schedule of future (projected) sales of the company Oruka Therapeutics Inc")
Future (projected) sales of companies in the market segment - Pharma skin
Oruka Therapeutics is a biopharmaceutical company developing new treatments for chronic skin diseases such as psoriasis. The company strives to create more effective and safer drugs. This chart shows the forecast for the entire pharmaceutical market, where dermatology is a large and competitive segment with a constant need for innovation.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-skin&v=1772676195487 "Schedule of future (projected) sales of companies in the market segment - Pharma skin")
Future (projected) sales of the market as a whole
Oruka Therapeutics is a biotech company developing new treatments for chronic skin diseases such as psoriasis. Its potential lies in developing more convenient and effective drugs. This chart reflects the overall investment climate, and Oruka's research progress is a bet on innovation in dermatology, a large and competitive market.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772676195557 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Oruka Therapeutics Inc
Oruka Therapeutics is a biotech company developing new treatments for chronic skin diseases such as psoriasis. While in early-stage research, it is actively investing in its scientific platform. This chart shows its net losses—the price the company pays for trying to create more effective and safer medications for millions of patients.
Market segment marginality - Pharma skin
Oruka Therapeutics is a clinical-stage biopharmaceutical company specializing in the development of new treatments for chronic skin diseases such as psoriasis. Profitability is a long-term goal. This chart reflects clinical trial costs. Investors analyze it to assess the company's potential in the large dermatology market.
Market marginality as a whole
Oruka Therapeutics is a biotech company developing new treatments for chronic skin diseases such as psoriasis. They are focused on creating more effective and safer drugs. This overall profitability curve is not directly relevant to them. Their future depends on scientific progress and the success of their clinical programs in dermatology.
Employees in the company, segment and market as a whole
Number of employees in the company Oruka Therapeutics Inc
Oruka Therapeutics is a clinical-stage biotech company developing treatments for chronic skin diseases. Its small team consists of scientists and drug development specialists. Growth on this chart will indicate progress in clinical trials and expansion of its research activities.
Share of the company's employees Oruka Therapeutics Inc within the market segment - Pharma skin
Oruka Therapeutics is an early-stage biotech company developing drugs to treat chronic skin diseases such as psoriasis. This chart shows its share of the total number of researchers in this field. It reflects the size of its scientific team, which is working to develop new therapeutic approaches that have the potential to change the lives of millions of patients.
Number of employees in the market segment - Pharma skin
Oruka Therapeutics Inc. is a clinical-stage biopharmaceutical company developing new treatments for chronic skin diseases. This chart reflects employment trends in the field of dermatology. The growing number of scientists and clinicians in this field signals a strong demand for more effective and safer drugs for conditions such as psoriasis and atopic dermatitis.
Number of employees in the market as a whole
Oruka Therapeutics is a biotechnology company developing new treatments for chronic skin diseases such as psoriasis. Its approach is focused on creating more effective and safer drugs. This achievement demonstrates how innovations in dermatology, where Oruka works, can improve the quality of life for millions of people and stimulate employment growth in the pharmaceutical sector.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Oruka Therapeutics Inc (ORKA)
Oruka Therapeutics is a biotech company specializing in skin diseases. This chart represents a pure intellectual capital valuation. The market values its scientific platform's potential to develop new treatments, not its staff. The chart shows the high future value investors are placing on this technology per scientist.
%20of%20the%20company%20Oruka%20Therapeutics%20Inc%20(ORKA)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Oruka-Therapeutics-Inc-ORKA&v=1772676195755 "Chart of market capitalization per employee (in thousands of dollars) of the company Oruka Therapeutics Inc (ORKA)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma skin
Oruka Therapeutics is a biotech company developing treatments for chronic skin diseases such as psoriasis. Its value is based on its research potential. This chart demonstrates a high valuation of its intellectual capital and future prospects based on its small staff of highly qualified scientists.
%20by%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-skin&v=1772676195779 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma skin")
Market capitalization per employee (in thousands of dollars) for the overall market
Oruka Therapeutics is a biotech company focused on developing new treatments for chronic skin diseases. This chart provides a glimpse into the market valuation of this knowledge-intensive business. For Oruka, its high market capitalization per employee reflects not current sales, but the enormous potential of its research and development and the value of its intellectual property.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772676195791 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Oruka Therapeutics Inc (ORKA)
Oruka Therapeutics is a clinical-stage biotech company specializing in developing new treatments for chronic skin diseases such as psoriasis. This is R&D. This chart shows capital burn: the amount the company spends on each scientist working to create a more effective and convenient drug.
%20Chart%20Oruka%20Therapeutics%20Inc%20(ORKA)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Oruka-Therapeutics-Inc-ORKA&v=1772676195804 "Company Profit Per Employee (in thousands of dollars) Chart Oruka Therapeutics Inc (ORKA)")
Profit per employee (in thousands of dollars) in the market segment - Pharma skin
Oruka Therapeutics (ORKA) is a preclinical biotechnology company developing new treatments for chronic skin diseases such as psoriasis. This loss per employee reflects the high cost of R&D for creating new molecules.
%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-skin&v=1772676195844 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma skin")
Profit per employee (in thousands of dollars) for the market as a whole
Oruka Therapeutics is a clinical-stage biotech company specializing in the treatment of skin diseases (such as psoriasis). It's an R&D company and has no profit. This chart shows the company's capital burn rate: the operating loss per research team developing a new drug.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772676195872 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Oruka Therapeutics Inc (ORKA)
Oruka Therapeutics is a biotech company developing drugs for the treatment of chronic skin diseases. This chart reflects the initial stages of monetization of its scientific platform. Growth in revenue per employee will likely be driven by partnerships with large pharmaceutical companies interested in its developments.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Oruka-Therapeutics-Inc-ORKA&v=1772676195913 "Sales chart per company employee Oruka Therapeutics Inc (ORKA)")
Sales per employee in the market segment - Pharma skin
Oruka Therapeutics (ORKA) is a biotech company specializing in developing treatments for chronic skin diseases and inflammation (dermatology). This chart shows how productive their research team is, measuring revenue (from partnerships) per researcher compared to competitors.
Sales per employee for the market as a whole
Oruka Therapeutics (ORKA) is a preclinical biotech company focused on developing new treatments for chronic skin diseases such as psoriasis. The company has no products on the market yet. This graph reflects a typical R&D situation: the entire research and development staff generates intellectual property, not operating revenue.
Short shares by company, segment and market as a whole
Shares shorted by company Oruka Therapeutics Inc (ORKA)
Oruka Therapeutics Inc. is a biotech company focused on treating chronic skin diseases (such as psoriasis) using novel approaches. The bearish sentiment shown in this chart reflects investors' bets that its candidates will be unable to compete with existing blockbusters from major pharmaceutical companies.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Oruka-Therapeutics-Inc-ORKA&v=1772676196030 "Short Shares Chart for the Company Oruka Therapeutics Inc (ORKA)")
Shares shorted by market segment - Pharma skin
Oruka Therapeutics is a biotech company developing drugs to treat chronic skin conditions such as psoriasis. This chart shows bearish sentiment. "Shorts" here are betting that their drugs won't be competitive with existing blockbusters.
Shares shorted by the overall market
Oruka Therapeutics (ORKA) is a biotech company developing treatments for chronic skin diseases such as psoriasis. It's an R&D-dependent sector. This chart shows the overall market fear. When it rises, investors flee speculative assets. Biotech stocks without stable revenue, like ORKA, often fall along with the market due to the general "risk-off" sentiment.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Oruka Therapeutics Inc (ORKA)
Oruka Therapeutics is a biotech company operating in the competitive field of treating psoriasis and other skin conditions. This chart measures the level of hype and hope. It shows when the stock is "overheated" (overbought) based on early data or "oversold" due to a general cooling in the sector or fears of competitors.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Oruka-Therapeutics-Inc-ORKA&v=1772676196129 "RSI 14 indicator chart for the company's stock Oruka Therapeutics Inc (ORKA)")
RSI 14 Market Segment - Pharma skin
Oruka Therapeutics is a preclinical biotech company focused on developing new treatments for chronic skin diseases such as psoriasis. This chart measures the collective excitement in the dermatology biotech sector. It helps determine whether the entire segment is overheated by expectations of clinical success.
RSI 14 for the overall market
Oruka Therapeutics (ORKA) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic poses the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ORKA (Oruka Therapeutics Inc)
Oruka Therapeutics is an early-stage biotech focused on treating chronic skin diseases such as psoriasis. This chart shows the average 12-month forecast of analysts. It represents their collective, highly speculative bet on the scientific potential of the company's platform.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ORKA-Oruka-Therapeutics-Inc&v=1772676196148 "A chart showing analyst consensus forecasts for the expected stock price. ORKA (Oruka Therapeutics Inc)")
The difference between the consensus estimate and the actual stock price ORKA (Oruka Therapeutics Inc)
Oruka (recent IPO) is a biotech company developing new treatments for chronic inflammatory skin diseases (dermatology). This is an R&D bet on the company's scientific platform. This chart shows the difference between the consensus estimate and the price. It reflects analysts' belief in its potential in a competitive market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ORKA-Oruka-Therapeutics-Inc&v=1772676196165 "A chart showing the difference between the consensus forecast and the actual stock price. ORKA (Oruka Therapeutics Inc)")
Analyst consensus forecast for stock prices by market segment - Pharma skin
Oruka Therapeutics is a biotech company developing new biologic drugs (antibodies) for the treatment of chronic skin diseases such as psoriasis and atopic dermatitis. This chart shows general expectations for the dermatology sector, reflecting experts' confidence in the success of R&D in this competitive market.
Analysts' consensus forecast for the overall market share price
Oruka Therapeutics (ORKA) is an R&D biotech focused on skin inflammation (psoriasis). They're burning cash. This chart, reflecting the economic consensus, reflects their risk appetite. If the consensus is negative (downturn), investors flee cash-burning, pre-profit biotechs.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Oruka Therapeutics Inc
Oruka is a biotech company focused on treating chronic inflammatory diseases, primarily skin diseases (psoriasis). This chart is a pure indicator of biotech expectations. It doesn't reflect current revenue, but rather an aggregate assessment of their scientific data, clinical trial progress, and market confidence in their R&D pipeline's ability to compete in this hot market.
AKIMA Market Segment Index - Pharma skin
Oruka (ORKA) is a clinical-stage biotech focused on dermatology (skin); the company is developing a new generation of antibodies for the treatment of chronic inflammatory diseases (psoriasis). This summary metric evaluates R&D. The graph shows the average value for the segment. This is a benchmark: how does this R&D rate (ORKA) differentiate it from the average pharma company?
The AKIM Index for the overall market
Oruka Therapeutics is a biotech company developing biologics for the treatment of chronic skin diseases (psoriasis). It competes with blockbusters. This chart, reflecting the market average, provides a macro backdrop. It helps assess how this ambitious early-stage company stacks up against the backdrop of overall economic trends and competition.
